EUVIMEDEUVIMED entdecken
Open Access

Off‑label and unapproved pediatric drug utilization: A meta‑analysis

Xingxing Yuan, Jiawei Gao, Liuxin Yang, Yurong Tan, Ousman Bajinka

Experimental and Therapeutic Medicine · 30.08.2024 · 28 (5)

DOI: 10.3892/etm.2024.12701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 30.08.2024. Verfasst von Xingxing Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150006, P.R. China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite legislative enforcement on authorized drugs, off-label and unapproved pediatric drug use is prevalent. The present study aimed to assess the global prevalence of off-label and unlicensed prescriptions among hospitalized children via meta-analysis. A comprehensive examination of articles published between 1990 and 2023 from the PubMed, Scopus, Excerpta Medica Database, Web of Science and Google Scholar databases was conducted. Key word-based advanced searches were executed using the aforementioned databases. A total of 45 studies that reported the prescriptions of off-label and unlicensed drugs to pediatric patients were included. The global prevalence of off-label and unlicensed drug prescriptions to children in pediatrics or neonatal departments was 56%. Patient sample sizes varied from 40-13,426, with a range of 240-8,891 total prescriptions issued. Of the 45 studies examined, 22 studies originated from Europe, 13 from Asia, 3 from South America, 3 from Africa, and 2 each from North America and Australia. Africa had the highest prevalence rate at 66%, followed by Asia, South America, North America, Australia and Europe. The present meta-analysis demonstrated that the prevalence of off-label and unlicensed drug prescriptions given to pediatric patients was notably high and geographically diverse. Therefore, drug authorities should standardize pediatric prescription practices in future.

Schlagwörter

Stichwörter der Autor:innen

licensed drugoff-label prescriptionspediatricsunlicensed prescribing

Autor:innen und Institutionen

  • Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150006, P.R. China.
  • First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China.
  • Department of Medical Microbiology, Central South University, Changsha, Hunan 410078, P.R. China.

Zitieren

APA

Yuan, X., Gao, J., Yang, L., Tan, Y., & Bajinka, O. (2024). Off‑label and unapproved pediatric drug utilization: A meta‑analysis. Experimental and Therapeutic Medicine, 28(5). https://doi.org/10.3892/etm.2024.12701

Vancouver

Yuan X, Gao J, Yang L, Tan Y, Bajinka O. Off‑label and unapproved pediatric drug utilization: A meta‑analysis. Experimental and Therapeutic Medicine. 2024;28(5). doi:10.3892/etm.2024.12701

BibTeX
@article{Yuan2024,
  author = {Yuan, Xingxing and Gao, Jiawei and Yang, Liuxin and Tan, Yurong and Bajinka, Ousman},
  title = {Off‑label and unapproved pediatric drug utilization: A meta‑analysis},
  journal = {Experimental and Therapeutic Medicine},
  year = {2024},
  volume = {28},
  number = {5},
  doi = {10.3892/etm.2024.12701}
}
Kostenlos starten →